Sign in

Filings · 2026-11-03

Tue, Nov 3

Filings that arrived on this Korea-time day

checked · Filings arrive within legal deadlines (Form 4: 2 business days after the trade; 13D: 5 business days; 13G: up to 45 days after quarter end). Dates shown are filing dates, not trade dates.

US insiders reported 14 open-market buys ($163M) and 26 sales ($103M). 39 Schedule 13D/13G filings, 8 of them first-time 13D.

14Insider buys
26Insider sales
39US 13D/13G

Stocks several insiders bought

2+ insiders · last 30 days
StockInsidersBought ($)Last trade
Rollins today
ROL
299.9M10/29
Aspen Neuroscience today
ASPE
238.0M11/2
Bambusa Therapeutics today
BBTX
212.0M11/2
Rent The Runway
RENT · same date and price (often a company programme)
36.1M10/21
Bank Bradesco
BBD
271.4M9/1
Borr Drilling
BORR
244.5M10/15
Rapport Therapeutics
RAPP
221.3M10/28
Applied Digital
APLD
26.7M10/16
City Therapeutics
CTY
26.1M10/19
TRex Bio
TRXB
23.8M10/13

Open-market purchases of $250K or more reported on Form 4. Several insiders buying is a reported fact, not a forecast.

Largest insider buys

SEC Form 4
StockInsiderTradeAmount ($)Traded
Rollins
ROLR. Randall Rollins Voting Trust U/a Dated August 25, 1994 · 10% owner
 R. Randall Rollins Voting Trust U/a Dated August 25, 1994
10% owner
 Buy50.0M10/29
Rollins
ROLLor Inc · 10% owner
 Lor Inc
10% owner
 Buy50.0M10/29
Aspen Neuroscience
ASPEArch Venture Fund X, L.P. · 10% owner
 Arch Venture Fund X, L.P.
10% owner
 Buy20.0M11/2
Aspen Neuroscience
ASPEArch Venture Partners Xiv, L.P. · 10% owner
 Arch Venture Partners Xiv, L.P.
10% owner
 Buy18.0M11/2
Corebridge Financial
CRBGNippon Life Insurance Co · 10% owner
 Nippon Life Insurance Co
10% owner
 Buy Plan8.8M10/29
Bambusa Therapeutics
BBTXSalvia Investment Gmbh · 10% owner
 Salvia Investment Gmbh
10% owner
 Buy6.0M11/2
Bambusa Therapeutics
BBTXHelmut Wolfgang Jeggle · 10% owner
 Helmut Wolfgang Jeggle
10% owner
 Buy6.0M11/2
Hudson Technologies Inc /Ny
HDSNHartree Partners, LP · 10% owner
 Hartree Partners, LP
10% owner
 Buy1.3M11/2

First-time 13D filings

active stakes over 5%
StockHolderStakeChangeFiled
Penguin Solutions
PENGSK Hynix
 SK Hynix
Active
 9.1%New filing11/3
Dine Brands Global
DINArkhouse Management
 Arkhouse Management
Active
 4.3%New filing11/2
Dine Brands Global
DINCobblers Cove Capital
 Cobblers Cove Capital
Active
 0.0%New filing11/2
MSG Rangers
MSGRJames L. Dolan
 James L. Dolan
Active
 8.1%New filing11/2
Vertical Data
VDTASoni Deven
 Soni Deven
Active
 18.7%New filing11/2
Narragansett Bancorp
NARANarragansett Financial
 Narragansett Financial
Active
 55.0%New filing11/2
Seer
SEERBML Investment Partners, L.P.
 BML Investment Partners, L.P.
Active
 3.9%New filing11/2
Maxcyte
MXCTLiontrust Investment Partners LLP
 Liontrust Investment Partners LLP
Active
 4.9%New filing11/2

Largest insider sales

SEC Form 4
StockInsiderTradeAmount ($)Traded
Scorpio Tankers
STNGEmanuele Lauro · CEO
 Emanuele Lauro
CEO
 Sell21.8M10/30
Lenz Therapeutics
LENZRa Capital Management, L.P. · 10% owner
 Ra Capital Management, L.P.
10% owner
 Sell9.1M10/29
United Therapeutics
UTHRMartine A Rothblatt · CEO
 Martine A Rothblatt
CEO
 Sell Plan5.7M10/30
Gilead Sciences
GILDDaniel Patrick O'Day · CEO
 Daniel Patrick O'Day
CEO
 Sell Plan5.3M11/2
CrowdStrike Holdings
CRWDGeorge Kurtz · CEO
 George Kurtz
CEO
 Sell Plan5.1M10/30

Discussion

sign in to join · no buy/sell tips

Loading…

Restated and computed from SEC (13F, 13D/G, Form 4) and DART filings and NPS public data. Filings describe a past date and may differ from current holdings (13F: quarter end, up to 45 days later). Not investment advice.
Sources: SEC EDGAR, DART, data.go.kr (NPS), OpenFIGI. See Methodology for how figures are computed.